Sara Salama1, Majid Khan2, Amirali Shanechi2, Michael Levy3, Izlem Izbudak2. 1. Department of Neurology and Psychiatry, University of Alexandria, Alexandria, Egypt/Department of Neurology, Johns Hopkins University, Baltimore, MD, USA. 2. Department of Radiology, Johns Hopkins University, Baltimore, MD, USA. 3. Department of Neurology, Johns Hopkins University, Baltimore, MD, USA/ Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: MOG antibody and AQP4 antibody seropositive diseases are immunologically distinct subtypes of neuromyelitis optica spectrum disorders (NMOSD) with similar clinical presentations. MRI findings can be instrumental in distinguishing MOG antibody disease from AQP4 antibody NMOSD. OBJECTIVES: The aim of this study is to characterize the neuroradiological differences between MOG antibody disease and AQP4 antibody NMOSD with the aim to distinguish between the two entities. METHODS: This is a retrospective study of 26 MOG and 25 AQP4 seropositive patients in which MRI features of the brain, spinal cord, and orbit were compared. RESULTS: The majority of the abnormal findings in the MOG cohort were located on orbital MRIs, while spinal cord magnetic resonance (MR) abnormalities were more common in the AQP4 cohort. Brain abnormalities showed some overlap, but cortical gray/juxtacortical white matter involvement was distinct to MOG patients, while area postrema involvement was a rare feature. CONCLUSION: Cortical gray/juxtacortical white matter lesions on brain MRI might help distinguish MOG antibody disease from AQP4-positive NMOSD. These findings could be of value in distinguishing the two entities as early as the first presentation.
BACKGROUND:MOG antibody and AQP4 antibody seropositive diseases are immunologically distinct subtypes of neuromyelitis optica spectrum disorders (NMOSD) with similar clinical presentations. MRI findings can be instrumental in distinguishing MOG antibody disease from AQP4 antibody NMOSD. OBJECTIVES: The aim of this study is to characterize the neuroradiological differences between MOG antibody disease and AQP4 antibody NMOSD with the aim to distinguish between the two entities. METHODS: This is a retrospective study of 26 MOG and 25 AQP4 seropositive patients in which MRI features of the brain, spinal cord, and orbit were compared. RESULTS: The majority of the abnormal findings in the MOG cohort were located on orbital MRIs, while spinal cord magnetic resonance (MR) abnormalities were more common in the AQP4 cohort. Brain abnormalities showed some overlap, but cortical gray/juxtacortical white matter involvement was distinct to MOGpatients, while area postrema involvement was a rare feature. CONCLUSION: Cortical gray/juxtacortical white matter lesions on brain MRI might help distinguish MOG antibody disease from AQP4-positive NMOSD. These findings could be of value in distinguishing the two entities as early as the first presentation.
Entities:
Keywords:
AQP4 antibody; MOG antibody; NMOSD; magnetic resonance imaging
Authors: Yujuan Jiao; James P Fryer; Vanda A Lennon; Sarah M Jenkins; Amy M L Quek; Carin Y Smith; Andrew McKeon; Chiara Costanzi; Raffaele Iorio; Brian G Weinshenker; Dean M Wingerchuk; Elizabeth A Shuster; Claudia F Lucchinetti; Sean J Pittock Journal: Neurology Date: 2013-08-30 Impact factor: 9.910
Authors: Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann Journal: J Neuroinflammation Date: 2016-09-27 Impact factor: 8.322
Authors: Sudarshini Ramanathan; Kristina Prelog; Elizabeth H Barnes; Esther M Tantsis; Stephen W Reddel; Andrew P D Henderson; Steve Vucic; Mark P Gorman; Leslie A Benson; Gulay Alper; Catherine J Riney; Michael Barnett; John D E Parratt; Todd A Hardy; Richard J Leventer; Vera Merheb; Margherita Nosadini; Victor S C Fung; Fabienne Brilot; Russell C Dale Journal: Mult Scler Date: 2015-07-10 Impact factor: 6.312
Authors: Sangeeta Khanna; Aseem Sharma; Julie Huecker; Mae Gordon; Robert T Naismith; Gregory P Van Stavern Journal: J Neuroophthalmol Date: 2012-09 Impact factor: 3.042
Authors: Melania Spadaro; Lisa Ann Gerdes; Markus Krumbholz; Birgit Ertl-Wagner; Franziska Sabrina Thaler; Elisabeth Schuh; Imke Metz; Astrid Blaschek; Andrea Dick; Wolfgang Brück; Reinhard Hohlfeld; Edgar Meinl; Tania Kümpfel Journal: Neurol Neuroimmunol Neuroinflamm Date: 2016-06-30
Authors: Ziyan Li; Hong Sun; Xiao Fan; Ping Yuan; Yan Jiang; Peng Wu; Min Zhong; Jiannan Ma; Li Jiang; Xiujuan Li Journal: Front Neurol Date: 2021-03-26 Impact factor: 4.003